U.S. POINTER: Lessons learned about delivery of a multi‐domain lifestyle intervention during the COVID‐19 pandemic
Authors: Baker Laura D , Espeland Mark A , Whitmer Rachel A , Kivipelto Miia , Antkowiak Susan , Chavin Melanie , Cleveland Maryjo , Correia Stephen , Day Claire E , Elbein Richard , Farias Sarah Tomaszewski , Gitelman Darren R , Graef Sarah , Katula Jeffrey A , Lambert Katherine , Leng Xiaoyan Iris , Lovato Laura , Morris Martha Clare , Ngandu Tiia , Papp Kate V , Pavlik Valory , Raman Rema , Robertson Julia , Rushing Scott , Salloway Stephen P , Solomon Alina , Tangney Christy C , Ventrelle Jennifer , Williams Benjamin J , Williamson Jeff D , Wilmoth Sharon , Wing Rena R , Woolard Nancy , Yu Melissa , Snyder Heather M , Carrillo Maria C ,   U.S. POINTER Study Group
Published: December 2021

AbstractBackgroundU.S. POINTER is testing whether multidomain lifestyle interventions focused on physical exercise, nutrition, cognitive challenge, and risk factor management reduces risk of cognitive decline in a heterogeneous population of at‐risk older adults in America. The study adapts the FINGER (Finnish Intervention Geriatric Study to Prevent Cognitive Impairment and Disability) interventions to fit the United States culture and delivers the intervention within the community at 5 sites across the country.MethodU.S. POINTER is a 2‐year RCT that will enroll 2000 cognitively unimpaired older adults who are at risk for cognitive decline due sedentary lifestyle, poor diet and other factors. Participants are randomized to one of two lifestyle intervention groups that differ in format and intensity. In 2020, the COVID‐19 pandemic presented a number of challenges for the study that affected recruitment, assessment schedules, and intervention delivery.ResultAs of March 2020, when COVID‐19 incidence was on an exponential rise in the US, 240 participants had been enrolled in U.S. POINTER. In response to local and national safety mandates, study activities were paused from March 23rd to July 13th. During the pause, sites remained in contact with study candidates and enrolled participants to provide ongoing support to keep them engaged in the trial. Enrollees also received regular telephone calls to encourage continued adherence to their assigned lifestyle intervention. In response to the multiple pandemic‐related challenges, study protocols and procedures were adapted to facilitate and encourage participant adherence to intervention activities. At study re‐start, retention was 98%. Despite climbing COVID‐19 infection rates nationwide, enrollment at all 5 sites has continued at a steady rate (N=540 as of Jan2021), virtual Team Meeting attendance for both lifestyle groups exceeds 80%, and participants continue to successfully work toward their intervention goals.ConclusionThe COVID‐19 pandemic presented unprecedented challenges, but it also provided a unique opportunity to adapt intervention delivery so that a nonpharmacological community‐based trial could continue – even during a debilitating global health crisis. U.S. POINTER’s adaptations to pandemic‐related challenges may ultimately increase the resilience of its interventions to even the most challenging of circumstances that older adults will face now and in the future.